|
Treatment
Options > Approved
Drugs for Children
Approved
Drugs for Children
Chronic hepatitis B is normally a mild disease in children and
teens. Most children can expect to live full, healthy lives unmarked
by visible symptoms. In some children, however, the virus can cause
serious liver damage. These children will need medical intervention
and treatment.
ALL children with chronic hepatitis B should be seen regularly
by a pediatric liver specialist or knowledgeable doctor whether
they are on treatment or not. Visits may be every six months or
once a year, depending on your child's situation. A physical exam,
blood tests, and possible ultrasounds of the liver are part of the
usual visit.
Approved Treatments
There are currently two approved treatment options available in
the United States for children with chronic hepatitis B.
Interferon
alpha (Intron A) is an injection usually given three times a
week for 6 months to a year. Children generally experience fewer
side effects than adults, but they can include flu-like symptoms.
Lamivudine
(Epivir-HBV, Zeffix, Heptodin) is a pill that is taken once a day
for at least one year or more. There are almost no side effects.
Not every child (or adult) with chronic hepatitis B needs
to be treated. A pediatric liver specialist should evaluate
your child to see if she or he is a candidate for treatment based
on a physical exam, blood tests, and other test results. Treatment
appears to be of greatest benefit to those who show signs of active
liver disease.
|
Further Reading
More information about treatment for children with
hepatitis B can be found in the PKIDs
Pediatric Hepatitis Report, published by the national non-profit PKIDs.
Visit the HBF Drug Watch for approved hepatitis B drugs and those
in development.
Pharmaceutical Support Programs
|